Financials
- Market Capitalization 1.84 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2043 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 21.98 USD | -4.60% | -6.43% | +18.24% | +94.51% | 1.86 B USD | ||
| 2044 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.15 USD | -2.63% | -4.41% | +28.36% | +94.94% | 1.85 B USD | ||
| 2056 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.46 USD | -6.12% | -10.24% | -3.38% | +143.27% | 1.83 B USD | ||
| 2057 | AAPG Ascentage Pharma Group International - American Depository Shar | 19.62 USD | -1.75% | +6.05% | +9.18% | -21.52% | 1.83 B USD |
Frequently asked questions about Precigen, Inc. - Common Stock
What is the Precigen, Inc. - Common Stock stock price today?
The current price of Precigen, Inc. - Common Stock (PGEN) is 5.17. Over the past 24 hours, the stock has changed by -2.82%. Follow the PGEN chart for real-time price dynamics.
What is the stock ticker of Precigen, Inc. - Common Stock?
Precigen, Inc. - Common Stock trades under the ticker PGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Precigen, Inc. - Common Stock stock going up?
PGEN has changed by -8.17% over the last week, +12.39% over the last month, and +163.78% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Precigen, Inc. - Common Stock net income for the last quarter?
Precigen, Inc. - Common Stock reported net income of -7.93 M for the last quarter. The previous quarter showed -23.5 M, which means net income changed by +66.26%.
How many employees does Precigen, Inc. - Common Stock have?
As of the latest available data, Precigen, Inc. - Common Stock has 47 employees. Workforce size can provide additional context about the company's scale and operations.
What is Precigen, Inc. - Common Stock EBITDA?
Precigen, Inc. - Common Stock EBITDA is -4.89 M, and its EBITDA margin is -21.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Precigen, Inc. - Common Stock stock?
You can buy Precigen, Inc. - Common Stock (PGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Precigen, Inc. - Common Stock stock?
Investing in Precigen, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PGEN chart and related analysis on metatrader.com as part of your research.